WHO ICTRP trial

A retrospective review on the use of Regional citrate Anticoagulation (RCA) in…

ACTRN12611000360910 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12611000360910
Public title A retrospective review on the use of Regional citrate Anticoagulation (RCA) in Continuous Venovenous Hemofiltration (CVVH) for critically ill patients
Scientific title In critically ill patients who required Continuous Venovenous Hemofiltration (CVVH), what is the effect of using Regional citrate anticoagulation (RCA) on circuit time, rate of correction of patient's metabolic acidosis and any untoward side effect?
Primary sponsor Dr Anne Leung
Secondary sponsors Dr Chan Choi Hung;Dr Shum Hoi Ping;Dr Chan King Chung;Dr Lai Kang Yiu;Dr Yan Wing Wa
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Observational
Phase Not Applicable
Countries Hong Kong
Conditions Critically ill patients who required continuous venovenous hemofiltration; Critically ill patients who required continuous venovenous hemofiltration;Renal and Urogenital - Kidney disease
Interventions To observe the effect of using citrate as regional anticoagulation during CVVH during the period from 1st Jul to 31st Dec 2010 To observe the effect on circuit lifetime, the rate of correction of metabolic acidosis and any untoward side…
Registration date Jul 4, 2011
Target size 30
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations